Health

The Montreal Biosafety Protocol
REUTERS

Key provisions of the U.N.-sponsored Biosafety Protocol approved by representatives of more than 130 countries in Montreal:

- Preamble recognizes risks/benefits of biotechnology and the need to protect biological diversity.

- Preamble emphasizes protocol "shall not be interpreted" as changing the rights and obligations of countries under other international pacts, such as the World Trade Organization.

- Preamble asserts trade and environmental accords should be mutually supportive and the protocol is not subordinate to other international pacts.

- Establishes a Biosafety Clearinghouse to share information about genetically modified organisms (GMOs). Countries must inform the body within 15 days of the approval of any crop varieties that could be used in food, animal feed and processing.

- Exporters must obtain an importing country‚s approval, through a procedure known as advance informed agreement (AIA), for initial shipments of GMOs, such as seeds and trees, intended for release into the environment.

- GMOs intended for food, feed and processing -- in other words, commodities -- are exempt from the AIA. But they must be labeled "may contain" GMOs and countries can decide whether or not to import them based on a scientific risk assessment. . Countries also may consider "socioeconomic factors," such as the impact on local farmers, consistent with their other international obligations when making import decisions.

- Negotiations on more detailed labeling requirements will proceed, with the requirement they be completed no later than two years after the protocol takes effect.

- New talks will be held on the issue of liability for any damage resulting >from the crossborder movements of GMOs. The goal is to finish in four years.

- If illegal shipments occur, the affected party can request the shipper to retrieve or destroy the GMO at its own expense.

- The protocol will go into effect after ratification by the 50th country or regional economic integration organization that is a party to the 1992 U.N. Convention on Biological Diversity. It will be subject to review at least every five years.

Reuters


Top or Page

Health Directory

Home